Two Healthcare Stocks I'm Watching Now - 3-Minute Stock Analysis
Up Next
8 videosUpwork Stock Looks Cheap (And Attractive)
August 25th, 2024
Should you buy Rivian stock? (February 2024)
February 23rd, 2024
Should you buy Lyft stock? (February 2024)
February 26th, 2024
Toast Inc Stock Analysis (January 2024)
January 6th, 2024
I was wrong about Meta stock (July 2023)
July 30th, 2023
Should you buy Aspen Aerogels stock? (August 2024)
August 6th, 2024
Should you buy Samsonite stock? (August 2024)
August 7th, 2024
Did Nike Stock Just Hit Bottom? 3-Minute Stock Analysis - June 2025
June 28th, 2025
Published first at https://www.3minutebreakdowns.com Two healthcare stocks I'm watching now. Dutch biotech company Uniqure soared over 300% in September after releasing data that showed positive results for its treatment of Huntington’s disease. Uniqure’s experimental gene therapy is delivered directly into the brain and the company’s 3 year study showed a 75% slowing progression of the devastating disease. The news was greeted with euphoria and hailed as a stunning breakthrough by the scientific community. And the therapy could also be highly lucrative for Uniqure with gene therapy treatments often costing upwards of 2 millions dollars. However, on November 3rd, Uniqure stock gave back almost all its gains as it emerged the FDA would no longer accept the company’s data as robust enough to support a BLA submission. Investors scaled back their bets as a new study could take years to develop. ABOUT ME Joe is the original founder of 3-minute Breakdowns and editor for Overlooked Alpha, the number one newsletter for overlooked investing ideas and stock market analysis. Joe evaluates companies from a business-first perspective, searching for things that the market has got wrong and waiting for the 'fat pitch'. LINKS My website: https://www.3minutebreakdowns.com/ Koyfin charts: https://www.koyfin.com/affiliate/overlooked-alpha/?via=3mb TikTok: https://www.tiktok.com/@overlookedalpha X: https://x.com/OverlookedAlpha DISCLAIMER & DISCLOSURE This content is for educational and entertainment purposes only. 3-Minute Breakdowns is not a registered investment advisor and does not provide financial recommendations (only opinions). The information is being presented without consideration of the investment objectives, risk tolerance, or financial circumstances of any specific investor and might not be suitable for all investors. Past performance is not indicative of future results. All investing involves risk, including the possible loss of principal. The author reserves the right to buy and sell or change his position in a particular stock at any time. This description contains affiliate links that allow you to find the items that I personally use and recommend. Thank you for your support.

